(0.37%) 5 118.98 points
(0.31%) 38 358 points
(0.35%) 15 984 points
(-0.75%) $83.22
(2.55%) $1.972
(0.09%) $2 349.20
(-0.07%) $27.52
(3.13%) $951.00
(-0.08%) $0.934
(-0.09%) $11.01
(-0.31%) $0.798
(1.51%) $93.26
-0.50% ¥ 996.00
Live Chart Being Loaded With Signals
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters...
Stats | |
---|---|
Dagens volum | 56 600.00 |
Gjennomsnittsvolum | 11 800.00 |
Markedsverdi | 10.40B |
EPS | ¥0 ( 2024-01-30 ) |
Neste inntjeningsdato | ( ¥0 ) 2024-05-13 |
Last Dividend | ¥30.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 26.11 |
ATR14 | ¥1.661 (0.17%) |
Volum Korrelasjon
DVx Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
DVx Inc. Korrelasjon - Valuta/Råvare
DVx Inc. Økonomi
Annual | 2022 |
Omsetning: | ¥47.48B |
Bruttogevinst: | ¥5.46B (11.49 %) |
EPS: | ¥90.21 |
FY | 2022 |
Omsetning: | ¥47.48B |
Bruttogevinst: | ¥5.46B (11.49 %) |
EPS: | ¥90.21 |
FY | 2022 |
Omsetning: | ¥45.50B |
Bruttogevinst: | ¥5.34B (11.73 %) |
EPS: | ¥83.56 |
FY | 2021 |
Omsetning: | ¥41.01B |
Bruttogevinst: | ¥4.96B (12.09 %) |
EPS: | ¥55.60 |
Financial Reports:
No articles found.
DVx Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥5.00 | 2010-03-29 |
Last Dividend | ¥30.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | ¥229.63 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.23 | -- |
Div. Sustainability Score | 6.93 | |
Div.Growth Potential Score | 3.61 | |
Div. Directional Score | 5.27 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8369.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7762.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6937.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6294.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5018.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
4220.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3434.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2540.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9468.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8097.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00861 | 1.500 | 9.83 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0175 | 1.200 | 9.42 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0432 | 1.500 | -0.631 | -0.947 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.617 | 0.800 | 6.92 | 5.53 | [1 - 3] |
quickRatioTTM | 1.439 | 0.800 | 6.24 | 4.99 | [0.8 - 2.5] |
cashRatioTTM | 0.563 | 1.500 | 7.98 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 3 364.07 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.107 | 1.000 | -1.548 | -1.548 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0183 | 1.000 | -1.634 | -1.634 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 2.03 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 6.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.16 | 1.000 | 7.46 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0432 | 2.50 | -0.406 | -0.947 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.02 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.833 | 1.500 | 1.114 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0186 | 1.000 | -2.03 | 0 | [0.1 - 0.5] |
Total Score | 3.61 |
DVx Inc.
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.